1. Home
  2. ABVX vs PRIM Comparison

ABVX vs PRIM Comparison

Compare ABVX & PRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • PRIM
  • Stock Information
  • Founded
  • ABVX 2013
  • PRIM 1960
  • Country
  • ABVX France
  • PRIM United States
  • Employees
  • ABVX N/A
  • PRIM N/A
  • Industry
  • ABVX
  • PRIM Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • ABVX
  • PRIM Industrials
  • Exchange
  • ABVX Nasdaq
  • PRIM Nasdaq
  • Market Cap
  • ABVX 6.7B
  • PRIM 6.6B
  • IPO Year
  • ABVX N/A
  • PRIM N/A
  • Fundamental
  • Price
  • ABVX $105.95
  • PRIM $125.58
  • Analyst Decision
  • ABVX Buy
  • PRIM Strong Buy
  • Analyst Count
  • ABVX 11
  • PRIM 14
  • Target Price
  • ABVX $110.36
  • PRIM $134.08
  • AVG Volume (30 Days)
  • ABVX 1.0M
  • PRIM 897.1K
  • Earning Date
  • ABVX 08-11-2025
  • PRIM 11-03-2025
  • Dividend Yield
  • ABVX N/A
  • PRIM 0.26%
  • EPS Growth
  • ABVX N/A
  • PRIM 66.70
  • EPS
  • ABVX N/A
  • PRIM 5.05
  • Revenue
  • ABVX $7,073,400.00
  • PRIM $7,458,609,000.00
  • Revenue This Year
  • ABVX $6.80
  • PRIM $14.00
  • Revenue Next Year
  • ABVX N/A
  • PRIM $8.60
  • P/E Ratio
  • ABVX N/A
  • PRIM $24.82
  • Revenue Growth
  • ABVX N/A
  • PRIM 21.45
  • 52 Week Low
  • ABVX $4.77
  • PRIM $49.10
  • 52 Week High
  • ABVX $108.00
  • PRIM $146.16
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 71.68
  • PRIM 40.09
  • Support Level
  • ABVX $96.10
  • PRIM $123.00
  • Resistance Level
  • ABVX $104.99
  • PRIM $145.40
  • Average True Range (ATR)
  • ABVX 4.36
  • PRIM 6.30
  • MACD
  • ABVX 0.42
  • PRIM -2.25
  • Stochastic Oscillator
  • ABVX 89.44
  • PRIM 16.67

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About PRIM Primoris Services Corporation

Primoris Services Corp is a provider of infrastructure services operating mainly in the United States and Canada. It provides a wide range of construction services, maintenance, replacement, fabrication and engineering services to a diversified base of customers. The reportable segments are the Utilities segment and the Energy segment. The Utilities segment operates in a range of services, including the installation and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communication systems. The Energy segment operates in a range of services that include engineering, procurement, and construction, retrofits, highway and bridge construction, demolition, site work, outages, pipeline construction and maintenance, and others.

Share on Social Networks: